Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 09:25 am Purchase |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
AVORO CAPITAL ADVISORS LLC | 2,565,555 9.100% |
1,155,555![]() (+81.95%) |
Filing History |
2024-02-14 09:23 am Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 13,411,111 9.900% |
2,786,111![]() (+26.22%) |
Filing History |
2024-02-14 09:22 am Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 27,400,000 9.300% |
600,000![]() (+2.24%) |
Filing History |
2024-02-14 09:21 am Purchase |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 2,288,888 9.900% |
628,888![]() (+37.88%) |
Filing History |
2024-02-14 09:20 am Sale |
2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-7,550,000![]() (Position Closed) |
Filing History |
2024-02-14 09:18 am Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-3,060,000![]() (Position Closed) |
Filing History |
2024-02-14 09:17 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
AVORO CAPITAL ADVISORS LLC | 3,755,555 6.500% |
655,555![]() (+21.15%) |
Filing History |
2024-02-14 09:15 am Sale |
2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
AVORO CAPITAL ADVISORS LLC | 3,775,000 6.800% |
-75,000![]() (-1.95%) |
Filing History |
2024-02-14 09:14 am Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
AVORO CAPITAL ADVISORS LLC | 4,535,000 9.100% |
210,000![]() (+4.86%) |
Filing History |
2024-02-14 09:13 am Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
AVORO CAPITAL ADVISORS LLC | 4,886,840 7.000% |
-668,715![]() (-12.04%) |
Filing History |
2024-02-14 09:12 am Purchase |
2023-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
AVORO CAPITAL ADVISORS LLC | 5,666,666 7.700% |
766,666![]() (+15.65%) |
Filing History |
2024-02-14 09:10 am Purchase |
2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
AVORO CAPITAL ADVISORS LLC | 6,583,332 9.990% |
6,583,332![]() (New Position) |
Filing History |
2024-02-14 09:09 am Purchase |
2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
AVORO CAPITAL ADVISORS LLC | 16,337,739 9.990% |
3,537,739![]() (+27.64%) |
Filing History |
2024-02-14 09:08 am Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
AVORO CAPITAL ADVISORS LLC | 2,125,597 5.900% |
2,125,597![]() (New Position) |
Filing History |
2024-02-14 09:07 am Purchase |
2023-12-31 | 13G | Structure Therapeutics Inc. GPCR |
AVORO CAPITAL ADVISORS LLC | 6,999,999 5.000% |
6,999,999![]() (New Position) |
Filing History |
2024-02-14 09:05 am Sale |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 2,858,888 6.100% |
-6,112![]() (-0.21%) |
Filing History |
2024-02-14 09:04 am Unchanged |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,150,000 5.800% |
0 (Unchanged) |
Filing History |
2024-02-14 09:02 am Purchase |
2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
AVORO CAPITAL ADVISORS LLC | 13,050,000 6.400% |
13,050,000![]() (New Position) |
Filing History |
2024-02-14 09:00 am Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-2,055,883![]() (Position Closed) |
Filing History |
2023-02-14 09:41 am Sale |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
AVORO CAPITAL ADVISORS LLC | 4,900,000 7.800% |
-85,000![]() (-1.71%) |
Filing History |